BioSpace News Archive

Pharm Country

AIkido Pharma Confirms Receipt of Unsolicited Offer

AIkido Pharma Inc. confirms that on August 9, 2022, the Company received an unsolicited offer from Mr. Shalom Auerbach to acquire all of the Company’s outstanding common stock for $8.00 per share in cash.

August 10, 2022
·
2 min read
Biotech Bay

Gallup Survey Estimates Nearly 30 Million U.S. Dog Owners Have Experienced Canine Cancer, with Many Saying it Negatively Impacted Their Own Quality of Life

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) has announced the publication of Gallup’s analysis of results from Take Charge of Canine Cancer, the first-ever nationally representative survey of U.S. dog owners’ experiences with the disease.

August 10, 2022
·
6 min read
Biotech Beach

Arcutis Launches ZORYVE™ (Roflumilast) Cream 0.3% in the United States for Treatment of Plaque Psoriasis in Individuals Age 12 and Older

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that ZORYVE (roflumilast) cream 0.3% for topical use is now available in the United States for the treatment of plaque psoriasis in people aged 12 and older.

August 10, 2022
·
5 min read
Pharm Country

Aro Biotherapeutics Receives FDA Orphan Drug Designation for ABX1100 for the Treatment of Pompe Disease

Aro Biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in the muscle, for the treatment of Pompe disease.

August 10, 2022
·
2 min read
BioMidwest

NxGen MDx Announces Monkeypox Testing in Michigan and Chicago

NxGen MDx begins offering testing in Michigan and Chicago, IL for monkeypox, shingles, and lesion-forming STIs including chancroid, syphilis, and herpes.

August 10, 2022
·
3 min read